Psychedelic therapy training for mental health professionals
Learn to navigate non-ordinary states to better serve your clients
Beckley Academy prepares and trains providers to support patients to heal their mental health challenges with Ketamine, Psilocybin and MDMA.
FDA clinical trials for psychedelic-assisted therapy (PAT) with MDMA and Psilocybin have shown potential for treating PTSD, depression, anxiety and other mental health issues. Ketamine-Assisted Therapy is a legal treatment today. Approval for MDMA treatment and Psilocybin is expected in 2024 and 2026, respectively.
Ketamine
MDMA
Psilocybin
Our trainings are:
Research-based
We draw from the latest clinical trials research and insights from practitioners with decades of experience.
Culturally-responsive
We honor the wisdom of indigenous people who have practiced with psychedelics for centuries and tend to the trauma of oppression, colonization, and racism.
Relationally-oriented
We focus on the overt and subtle aspects of relational dynamics and ethics during altered states of consciousness. Our training is designed using best practices for adult learners with an emphasis on behavioral health education (e.g., self-reflection and guided experiences).
Online & flexible
Our training is designed to easily fit into full personal and professional schedules. Each module is a combination of self-paced readings, guided reflection activities, and facilitated cohort meetings.
Who do we serve?
- Licensed mental health professionals: PhD, PSyD, MD, DO, LPC, LMFT, LCADAC, LICSW, LCSW, ACSW
- Mental health professionals on a licensing path: e.g., enrolled in a degree program
- Allied mental health professionals: Non-clinical social workers, pastoral counselors, & Indigenous ceremonial leaders
Questions about your eligibility? Feel free to email us: info@beckleyacademy.com
More about our first program:
Foundations of Psychedelic-Assisted Therapy (PAT)
Cohort begins March 13, 2023 and ends on June 30, 2023
Drawing from the decades of research developed by the Beckley Foundation and Amanda Feilding, as well as the seminal work of Janis Phelps, Carl Jung, Stanislav Grof, Kylea Taylor, and Friederike Meckel Fischer, among others, Foundations of Psychedelic-Assisted Therapy presents psychoanalytical, psychodynamic, somatic, and transpersonal perspectives of the unconscious and shadow material that emerges in non-ordinary states of consciousness.
100% Online | 13 weeks | 60 hours | Intimate cohort | Accessible tuition
Why Beckley?
Beckley Academy’s trainers, curriculum contributors, and leadership team have deep expertise in online education, behavioral health training, mental health, and psychedelic research with an array of experiences in organizations including MAPS, Johns Hopkins, Imperial College, Mount Sinai Psychedelic Psychotherapy Research and Trauma Center, Sensorimotor Psychotherapy Institute, King’s College, NYU and more.
Beckley Academy is a part of the Beckley Foundation ecosystem. Established in 1998 by Amanda Feilding, an early psychedelic researcher and thought partner to Albert Hofmann (the creator of LSD), the Beckley Foundation has been instrumental in conducting pioneering research which has spearheaded the psychedelic renaissance and influenced global drug policy.
“We have been stuck with SSRIs [such as Prozac or Zoloft] as our only tool for treating depression and meanwhile there has been an epidemic of mental illness.”
– Amanda Feilding, The Guardian.
Alongside Beckley Academy, Amanda’s vision includes Beckley Retreats, which enables access to safe, legal, and transformative psychedelic ceremonies; Beckley Psytech, which focuses on helping those with neurological and psychiatric disorders; and Beckley Waves, a venture studio dedicated to supporting companies to build care delivery infrastructure for psychedelic medicines and beyond.
Beckley Foundation has been featured in:
